3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide

C112H126Cl3N21O10 — CID 158550589

IUPAC3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide
SMILESCN1C(=O)C(c2ccccc2)(c2cccc(-c3cncc(Cl)n3)c2)N=C1N.COc1cc(-c2cccc(C3(C)N=C(N)N(CC4CCN(C(C)=O)CC4)C3=O)c2)c[n+]([O-])c1.Cc1cncc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)c1.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CC1CC1.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CCO
InChIInChI=1S/C26H39N5O2.C24H29N5O4.C22H22ClN3O.C20H16ClN5O.C20H20ClN3O2/c1-18-13-21(17-28-16-18)23(32)29-22-10-6-9-20(14-22)15-26(24(33)31(2)25(27)30-26)12-11-19-7-4-3-5-8-19;1-16(30)27-9-7-17(8-10-27)13-29-22(31)24(2,26-23(29)25)20-6-4-5-18(11-20)19-12-21(33-3)15-28(32)14-19;23-19-6-2-4-16(12-19)15-3-1-5-18(11-15)22(17-9-10-17)20(27)26(21(24)25-22)13-14-7-8-14;1-26-18(27)20(25-19(26)22,14-7-3-2-4-8-14)15-9-5-6-13(10-15)16-11-23-12-17(21)24-16;21-17-6-2-4-14(12-17)13-3-1-5-16(11-13)20(15-7-8-15)18(26)24(9-10-25)19(22)23-20/h13,16-17,19-20,22H,3-12,14-15H2,1-2H3,(H2,27,30)(H,29,32);4-6,11-12,14-15,17H,7-10,13H2,1-3H3,(H2,25,26);1-6,11-12,14,17H,7-10,13H2,(H2,24,25);2-12H,1H3,(H2,22,25);1-6,11-12,15,25H,7-10H2,(H2,22,23)/t20-,22+,26+;;;;/m0..../s1
InChIKeyHPQZSACCTVDGLM-MITDTIIXSA-N
MW2032.74 g/mol
LogP15.35
Rot. Bonds25

About 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide

3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide (PubChem CID 158550589) has the molecular formula C112H126Cl3N21O10 and a molecular weight of 2032.74 g/mol. Its IUPAC name is 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide.

Molecular Properties

Compound Name3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide
PubChem CID158550589
Molecular FormulaC112H126Cl3N21O10
Molecular Weight2032.74 g/mol
Exact Mass2029.91
IUPAC Name3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide
SMILESCN1C(=O)C(c2ccccc2)(c2cccc(-c3cncc(Cl)n3)c2)N=C1N.COc1cc(-c2cccc(C3(C)N=C(N)N(CC4CCN(C(C)=O)CC4)C3=O)c2)c[n+]([O-])c1.Cc1cncc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)c1.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CC1CC1.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CCO
InChIInChI=1S/C26H39N5O2.C24H29N5O4.C22H22ClN3O.C20H16ClN5O.C20H20ClN3O2/c1-18-13-21(17-28-16-18)23(32)29-22-10-6-9-20(14-22)15-26(24(33)31(2)25(27)30-26)12-11-19-7-4-3-5-8-19;1-16(30)27-9-7-17(8-10-27)13-29-22(31)24(2,26-23(29)25)20-6-4-5-18(11-20)19-12-21(33-3)15-28(32)14-19;23-19-6-2-4-16(12-19)15-3-1-5-18(11-15)22(17-9-10-17)20(27)26(21(24)25-22)13-14-7-8-14;1-26-18(27)20(25-19(26)22,14-7-3-2-4-8-14)15-9-5-6-13(10-15)16-11-23-12-17(21)24-16;21-17-6-2-4-14(12-17)13-3-1-5-16(11-13)20(15-7-8-15)18(26)24(9-10-25)19(22)23-20/h13,16-17,19-20,22H,3-12,14-15H2,1-2H3,(H2,27,30)(H,29,32);4-6,11-12,14-15,17H,7-10,13H2,1-3H3,(H2,25,26);1-6,11-12,14,17H,7-10,13H2,(H2,24,25);2-12H,1H3,(H2,22,25);1-6,11-12,15,25H,7-10H2,(H2,22,23)/t20-,22+,26+;;;;/m0..../s1
InChIKeyHPQZSACCTVDGLM-MITDTIIXSA-N
XLogP15.35
TPSA437.93 Ų
H-Bond Donors7
H-Bond Acceptors23
Rotatable Bonds25
Heavy Atoms146
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002032.74
LogP ≤ 515.35
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'N_oxide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(6S)-2-amino-6-[3-(3-chlorophenyl)phenyl]-3,6-dimethyl-5H-pyrimidin-4-one;1-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-3-(2-phenylethyl)urea;2-amino-5-[3-(5-cyclopropyl-3-pyridinyl)phenyl]-3-methyl-5-phenylimidazol-4-one;2-amino-5,5-diphenyl-3-[[1-(3-phenylpropanoyl)piperidin-4-yl]methyl]imidazol-4-one;(6S)-2-amino-6-[2-(3-methoxyphenyl)-4-pyridinyl]-3,6-dimethyl-5H-pyrimidin-4-one
CID 157428429
3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-chloro-2-methoxy-3-pyridinyl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(pyridin-2-ylmethyl)imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-3-carboxamide;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-6-oxo-1H-pyridine-3-carboxamide;2-amino-5-cyclopropyl-3-methyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one
CID 158000677
3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-3-pyridinyl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-ethoxyethyl)imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]benzamide;2-amino-5,5-diphenyl-3-[[(3S)-1-(2-phenylacetyl)piperidin-3-yl]methyl]imidazol-4-one;2-amino-5,5-diphenyl-3-[[(3R)-1-(2-phenylacetyl)piperidin-3-yl]methyl]imidazol-4-one
CID 158710219
3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclobutyl-3-methylimidazol-4-one;2-amino-5-[3-(5-chloro-3-pyridinyl)phenyl]-5-cyclobutyl-3-methylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-4-methoxybenzamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylbenzamide;2-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N,N-dipropylpyridine-4-carboxamide
CID 159689287
3-[(1-Acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one
CID 159984966

Frequently Asked Questions

What is the IUPAC name of 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide?
The IUPAC name of 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide (CID 158550589) is 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide.
What is the SMILES notation for 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide?
The canonical SMILES for 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide is CN1C(=O)C(c2ccccc2)(c2cccc(-c3cncc(Cl)n3)c2)N=C1N.COc1cc(-c2cccc(C3(C)N=C(N)N(CC4CCN(C(C)=O)CC4)C3=O)c2)c[n+]([O-])c1.Cc1cncc(C(=O)N[C@@H]2CCC[C@H](C[C@@]3(CCC4CCCCC4)N=C(N)N(C)C3=O)C2)c1.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CC1CC1.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CCO.
What is the InChIKey of 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide?
The InChIKey is HPQZSACCTVDGLM-MITDTIIXSA-N. The full InChI is InChI=1S/C26H39N5O2.C24H29N5O4.C22H22ClN3O.C20H16ClN5O.C20H20ClN3O2/c1-18-13-21(17-28-16-18)23(32)29-22-10-6-9-20(14-22)15-26(24(33)31(2)25(27)30-26)12-11-19-7-4-3-5-8-19;1-16(30)27-9-7-17(8-10-27)13-29-22(31)24(2,26-23(29)25)20-6-4-5-18(11-20)19-12-21(33-3)15-28(32)14-19;23-19-6-2-4-16(12-19)15-3-1-5-18(11-15)22(17-9-10-17)20(27)26(21(24)25-22)13-14-7-8-14;1-26-18(27)20(25-19(26)22,14-7-3-2-4-8-14)15-9-5-6-13(10-15)16-11-23-12-17(21)24-16;21-17-6-2-4-14(12-17)13-3-1-5-16(11-13)20(15-7-8-15)18(26)24(9-10-25)19(22)23-20/h13,16-17,19-20,22H,3-12,14-15H2,1-2H3,(H2,27,30)(H,29,32);4-6,11-12,14-15,17H,7-10,13H2,1-3H3,(H2,25,26);1-6,11-12,14,17H,7-10,13H2,(H2,24,25);2-12H,1H3,(H2,22,25);1-6,11-12,15,25H,7-10H2,(H2,22,23)/t20-,22+,26+;;;;/m0..../s1.
What are the key properties of 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide?
3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide has a molecular weight of 2032.74 g/mol, XLogP of 15.35, 25 rotatable bonds, 7 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(1-acetylpiperidin-4-yl)methyl]-2-amino-5-[3-(5-methoxy-1-oxidopyridin-1-ium-3-yl)phenyl]-5-methylimidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(cyclopropylmethyl)imidazol-4-one;2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-(2-hydroxyethyl)imidazol-4-one;2-amino-5-[3-(6-chloropyrazin-2-yl)phenyl]-3-methyl-5-phenylimidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-5-methylpyridine-3-carboxamide is sourced from PubChem (CID 158550589), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).